The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121107712 12110771 2 F 201507 20160908 20160224 20160922 EXP JP-ASTRAZENECA-2016SE18825 ASTRAZENECA 838.00 MON M Y 41.00000 KG 20160922 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121107712 12110771 1 PS ONGLYZA SAXAGLIPTIN HYDROCHLORIDE 1 Oral Y 22350 2.5 MG TABLET QD
121107712 12110771 2 SS DEPAKENE VALPROIC ACID 1 Oral 33800 MG Y 0 200 MG PROLONGED-RELEASE TABLET BID
121107712 12110771 3 SS DEPAKENE VALPROIC ACID 1 Oral 33800 MG Y 0 200 MG PROLONGED-RELEASE TABLET QD
121107712 12110771 4 SS DEPAKENE VALPROIC ACID 1 Oral 33800 MG Y 0 200 MG PROLONGED-RELEASE TABLET BID
121107712 12110771 5 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 60 UG INJECTION /wk
121107712 12110771 6 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 40 UG INJECTION /wk
121107712 12110771 7 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 10 UG INJECTION /wk
121107712 12110771 8 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 5 UG INJECTION /wk
121107712 12110771 9 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 15 UG INJECTION /wk
121107712 12110771 10 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 30 UG INJECTION /wk
121107712 12110771 11 SS NESP DARBEPOETIN ALFA 1 Intravenous (not otherwise specified) D 0 60 UG INJECTION /wk
121107712 12110771 12 C HUMULIN 3/7 2 Subcutaneous 0 4 IU INJECTION QD
121107712 12110771 13 C LACTULOSE. LACTULOSE 1 Oral 0 10 ML SYRUP BID
121107712 12110771 14 C NAUZELIN DOMPERIDONE 1 Oral 0 10 MG TABLET TID
121107712 12110771 15 C HERBAL NOS HERBALS 1 Oral 0 2.5 G TID
121107712 12110771 16 C VANCOMYCIN HYDROCHLORIDE. VANCOMYCIN HYDROCHLORIDE 1 Oral 0 5 G BID
121107712 12110771 17 C UNASYN AMPICILLIN SODIUMSULBACTAM SODIUM 1 Intravenous drip 0 3 G INJECTION QD
121107712 12110771 18 C BIOFERMIN R BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 Oral 0 1 G BID
121107712 12110771 19 C PURSENNID SENNOSIDES A AND B 1 Oral 0 24 MG TABLET QD
121107712 12110771 20 C BAYASPIRIN ASPIRIN 1 Oral 0 100 MG TABLET QD
121107712 12110771 21 C MUCOSTA REBAMIPIDE 1 Oral 0 100 MG TABLET TID
121107712 12110771 22 C RIONA FERRIC CITRATE ANHYDROUS 1 Oral 0 500 MG TABLET TID
121107712 12110771 23 C AZILVA AZILSARTAN KAMEDOXOMIL 1 Oral 0 40 MG TABLET QD
121107712 12110771 24 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 0 20 MG CAPSULE QD
121107712 12110771 25 C PLETAAL CILOSTAZOL 1 Oral 0 100 MG TABLET BID
121107712 12110771 26 C ADALAT CC NIFEDIPINE 1 Oral 0 20 MG TABLET BID
121107712 12110771 27 C ADALAT CC NIFEDIPINE 1 Oral 0 20 MG TABLET BID
121107712 12110771 28 C TRESIBA INSULIN DEGLUDEC 1 Subcutaneous 0 4 IU INJECTION QD
121107712 12110771 29 C SEIBULE MIGLITOL 1 Oral TID 0 TABLET
121107712 12110771 30 C GLUFAST MITIGLINIDE 1 Oral 0 10 MG TABLET BID
121107712 12110771 31 C ALEVIATIN PHENYTOIN SODIUM 1 Oral 0 100 MG TABLET BID
121107712 12110771 32 C CERCINE DIAZEPAM 1 Oral 0 2 MG TABLET QD
121107712 12110771 33 C ROCEPHINE CEFTRIAXONE SODIUM 1 Intravenous drip 0 1 G INJECTION QD
121107712 12110771 34 C VEEN-D DEXTROSE 1 Intravenous drip 0 500 ML INJECTION QD
121107712 12110771 35 C GASTER FAMOTIDINE 1 Intravenous (not otherwise specified) 0 5 MG INJECTION QD
121107712 12110771 36 C SUBVITAN 2 Intravenous (not otherwise specified) 0 5 ML INJECTION QD
121107712 12110771 37 C GLUCOSE DEXTROSE 1 Intravenous (not otherwise specified) 0 20 ML INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121107712 12110771 2 Epilepsy
121107712 12110771 3 Epilepsy
121107712 12110771 4 Epilepsy
121107712 12110771 12 Diabetes mellitus
121107712 12110771 13 Hyperammonaemia
121107712 12110771 14 Vomiting
121107712 12110771 15 Decreased appetite
121107712 12110771 16 Gastroenteritis staphylococcal
121107712 12110771 17 Pneumonia
121107712 12110771 18 Gastroenteritis staphylococcal
121107712 12110771 19 Constipation
121107712 12110771 20 Angina pectoris
121107712 12110771 21 Gastritis
121107712 12110771 22 Hyperphosphataemia
121107712 12110771 23 Hypertension
121107712 12110771 24 Gastrooesophageal reflux disease
121107712 12110771 25 Peripheral arterial occlusive disease
121107712 12110771 26 Peripheral arterial occlusive disease
121107712 12110771 27 Peripheral arterial occlusive disease
121107712 12110771 28 Diabetes mellitus
121107712 12110771 29 Diabetes mellitus
121107712 12110771 30 Diabetes mellitus
121107712 12110771 31 Epilepsy
121107712 12110771 32 Insomnia
121107712 12110771 33 Pneumonia
121107712 12110771 34 Hypophagia
121107712 12110771 35 Hypophagia
121107712 12110771 36 Hypophagia
121107712 12110771 37 Hypophagia

Outcome of event

Event ID CASEID OUTC COD
121107712 12110771 DE
121107712 12110771 HO
121107712 12110771 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121107712 12110771 Decreased appetite
121107712 12110771 Neutrophil count decreased
121107712 12110771 Platelet count decreased
121107712 12110771 Pneumonia
121107712 12110771 Red blood cell count decreased
121107712 12110771 Somnolence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121107712 12110771 1 20151114 0
121107712 12110771 2 20150710 20150729 0
121107712 12110771 3 20150804 20150903 0
121107712 12110771 4 20150904 20151022 0
121107712 12110771 5 20150714 0
121107712 12110771 6 20150721 20150728 0
121107712 12110771 7 20150804 20150825 0
121107712 12110771 8 20150901 20151005 0
121107712 12110771 9 20151013 20151013 0
121107712 12110771 10 20151020 20151103 0
121107712 12110771 11 20151110 20151117 0
121107712 12110771 12 20150624 20150715 0
121107712 12110771 13 20150704 0
121107712 12110771 14 20150704 20150802 0
121107712 12110771 15 20150804 20151028 0
121107712 12110771 16 20150711 20151024 0
121107712 12110771 17 20150728 20150803 0
121107712 12110771 18 20150711 20151024 0
121107712 12110771 19 20150704 0
121107712 12110771 20 20151114 0
121107712 12110771 21 20151114 0
121107712 12110771 22 20151020 0
121107712 12110771 23 20151114 0
121107712 12110771 24 20151114 0
121107712 12110771 25 20151020 0
121107712 12110771 26 20151114 0
121107712 12110771 27 20151111 20151114 0
121107712 12110771 28 20150622 0
121107712 12110771 29 20151011 20151114 0
121107712 12110771 30 20151101 20151114 0
121107712 12110771 31 20151102 20151114 0
121107712 12110771 32 20151102 20151105 0
121107712 12110771 33 20151114 20151118 0
121107712 12110771 34 20151114 20151118 0
121107712 12110771 35 20151114 20151118 0
121107712 12110771 36 20151114 20151118 0
121107712 12110771 37 20151114 20151118 0

Execution Time: 0.0068240165710449 seconds (ucode:5256268). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.